Salta alla navigazione principale
Salta alla ricerca
Salta al contenuto principale
Ordina per
Keyphrases
Overexpression
100%
Melanoma
100%
Nicotinamide Phosphoribosyltransferase (NAMPT)
100%
Inhibitor Resistant
100%
Phenotypic Plasticity
100%
Resistant Phenotypes
100%
BRAF Inhibitor (BRAFi)
100%
Metastatic Melanoma
44%
Overexpressing
22%
Invasiveness
11%
Drug Resistance
11%
Melanoma Cells
11%
Metastasis
11%
MEK Inhibitor (MEKi)
11%
Transcription Factor
11%
Highly Aggressive
11%
Tumorigenicity
11%
Stem Cells
11%
Clinical Benefit
11%
Multidrug Resistance Protein 1 (MDR1)
11%
Resistance Development
11%
Epithelial-to-mesenchymal Transition
11%
Tumor Growth
11%
Nicotinamide Adenine Dinucleotide (NAD+)
11%
Skin Cancer
11%
Energy Production
11%
Tumor Aggressiveness
11%
Transition Process
11%
Protein Kinase B
11%
Biosynthetic Enzymes
11%
Melanoma Patients
11%
MAPK Activation
11%
Knock
11%
Mesenchymal Phenotype
11%
Colony Formation
11%
Cas9 Protein
11%
B-Raf
11%
Stemness Properties
11%
Cancer Genome Atlas
11%
Gene Set Enrichment Analysis
11%
Side Population
11%
Zinc Finger E-box Binding Homeobox 1 (ZEB1)
11%
BRAF Inhibitor Resistance
11%
ABCC1
11%
CD133-positive Cell
11%
Medicine and Dentistry
Nicotinamide Phosphoribosyltransferase
100%
Melanoma
100%
Metastatic Melanoma
50%
Cell Line
25%
Drug Resistance
12%
Metastatic Carcinoma
12%
MEK Inhibitor
12%
Mitogen-Activated Protein Kinase
12%
Tumor Progression
12%
Transcription Factors
12%
Mesenchymal-Epithelial Transition
12%
Gene Expression System
12%
Protein Kinase B
12%
Upregulation
12%
Skin Cancer
12%
Melanoma Cell
12%
Nicotinamide Adenine Dinucleotide
12%
Stem Cell
12%
Carcinogenicity
12%
Colony Formation
12%
Knock Out
12%
Cas9
12%
Clustered Regularly Interspaced Short Palindromic Repeat
12%
The Cancer Genome Atlas
12%
Gene Set Enrichment
12%
Side Population
12%
Multidrug Resistance Associated Protein 1
12%
Biochemistry, Genetics and Molecular Biology
Nicotinamide Phosphoribosyltransferase
100%
Enzyme
12%
Mitogen-Activated Protein Kinase
12%
Upregulation
12%
Transcription Factors
12%
Stem Cell
12%
CD133
12%
Tumor Progression
12%
Gene Expression System
12%
Protein Kinase B
12%
Energy Yield
12%
Nicotinamide Adenine Dinucleotide
12%
Drug Resistance
12%
Mesenchymal-Epithelial Transition
12%
Colony Formation
12%
CRISPR/Cas9
12%
MEK Inhibitor
12%
ABCC1
12%
ZEB1
12%
Side Population
12%
Gene Set Enrichment
12%